CHO Plus Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

CHO Plus General Information

Description

Developer of mammalian cell lines designed for biopharmaceutical production. The company's cell lines are engineered to provide highly productive GMP-compliant cell lines to satisfy the clients' clinical and commercial manufacturing needs, enabling healthcare professionals to better tackle diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 329 Oyster Point Boulevard
  • South San Francisco, CA 94080
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CHO Plus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Mar-2021 Completed Startup
1. Accelerator/Incubator Completed Startup
To view CHO Plus’s complete valuation and funding history, request access »

CHO Plus Patents

CHO Plus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230399625-A1 Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines Pending 09-Jun-2022 0000000000
US-20240043810-A1 Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines Pending 09-Jun-2022 0000000000
US-20240167006-A1 High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype Pending 09-Jun-2022 00000000
EP-3980524-A1 Cell lines for high level production of protein-based pharmaceuticals Pending 10-Jun-2019 00000000
EP-3980524-A4 Cell lines for high level production of protein-based pharmaceuticals Pending 10-Jun-2019 C12N5/16 0
To view CHO Plus’s complete patent history, request access »

CHO Plus Executive Team (4)

Name Title Board Seat
Lawrence Forman Co-Founder & Chief Executive Officer
James Panek Chief Operating Officer
Joseph Tarnowski Ph.D Chief Technology & Business Officer
Lawrence Chasin Co-Founder & Chief Scientific Advisor
To view CHO Plus’s complete executive team members history, request access »

CHO Plus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CHO Plus Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
MBC BioLabs Accelerator/Incubator Minority 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view CHO Plus’s complete investors history, request access »

CHO Plus FAQs

  • When was CHO Plus founded?

    CHO Plus was founded in 2013.

  • Who is the founder of CHO Plus?

    Lawrence Forman and Lawrence Chasin are the founders of CHO Plus.

  • Who is the CEO of CHO Plus?

    Lawrence Forman is the CEO of CHO Plus.

  • Where is CHO Plus headquartered?

    CHO Plus is headquartered in South San Francisco, CA.

  • What is the size of CHO Plus?

    CHO Plus has 9 total employees.

  • What industry is CHO Plus in?

    CHO Plus’s primary industry is Biotechnology.

  • Is CHO Plus a private or public company?

    CHO Plus is a Private company.

  • What is CHO Plus’s current revenue?

    The current revenue for CHO Plus is 00000.

  • Who are CHO Plus’s investors?

    MBC BioLabs and QB3 have invested in CHO Plus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »